<DOC>
	<DOCNO>NCT01860144</DOCNO>
	<brief_summary>This observational , multicenter , prospective study evaluate use bevacizumab real clinical practice chinese patient metastatic colorectal cancer .</brief_summary>
	<brief_title>An Observational Study Bevacizumab Chinese Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>histologically confirm metastatic colorectal cancer patient Having initiate treatment bevacizumab nonmetastatic colorectal cancer patient recieved bevacizumab</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>bevacizumab</keyword>
	<keyword>overall survival</keyword>
	<keyword>adverse event</keyword>
	<keyword>tumor resection rate</keyword>
</DOC>